Genetics Generation Advancement Corp. (TPEX:4160)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
39.40
-0.10 (-0.25%)
Aug 19, 2026, 10:25 AM CST

TPEX:4160 Revenue

Genetics Generation Advancement had revenue of 150.38M TWD in the quarter ending June 30, 2026, with 3.65% growth. This brings the company's revenue in the last twelve months to 614.42M, up 0.10% year-over-year. In the year 2025, Genetics Generation Advancement had annual revenue of 603.11M, down -8.88%.

Revenue (ttm)
614.42M
Revenue Growth
+0.10%
P/S Ratio
1.72
Revenue / Employee
5.91M
Employees
104
Market Cap
1.05B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2025603.11M-58.74M-8.88%
Dec 31, 2024661.86M69.36M11.71%
Dec 31, 2023592.50M44.69M8.16%
Dec 31, 2022547.81M28.30M5.45%
Dec 31, 2021519.51M76.38M17.24%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Related Stocks

Company NameRevenue
BIONET1.26B
DIVA Laboratories894.67M
Kim Forest Enterprise599.63M
Welgene Biotech398.92M
Sofiva Genomics379.21M
Pharmigene187.88M
Puriblood Medical82.34M
Revenue Rankings